BCO vs MRNA · P/E 25, rev $5.01B vs rev $1.94B
Brinks Company (BCO) versus Moderna Inc (MRNA) — a side-by-side from cached financials, not a winner call.
Brinks Company (BCO) is a security & protection services company listed on US.
Moderna Inc (MRNA) is a biotechnology company listed on NASDAQ. It is led by Stephane Bancel.
Latest reported BCO revenue for 2024-12-31 was $5.01B. Net income was $174.7M. Revenue was up 2.8% from 2023-12-31 to 2024-12-31. BCO currently screens at market cap $3.97B and trailing P/E 25.4.
Latest reported MRNA revenue for 2025-12-31 was $1.94B. Net income was -$2.82B. Revenue was down 39.9% from 2024-12-31 to 2025-12-31. MRNA currently screens at market cap $24.52B.
BCO currently screens at market cap $3.97B and trailing P/E 25.4. MRNA currently screens at market cap $24.52B.
Not investment advice. Open the BCO and MRNA stock pages for the full models.
Not investment advice.